Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus. 2019

Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, 13, Place Pasteur, B.P.74, 1002, Belvédère, Tunis, Tunisia.

Gut microbiota plays an important role in the regulation of the immune system and host's metabolism. We aimed to characterize the gut microbiota of Tunisian participants with and without diabetes.We enrolled ten participants with type 1 diabetes mellitus (T1DM), ten patients with type 2 diabetes mellitus (T2DM), and 11 subjects without diabetes. Bacteria was quantified in fecal samples by quantitative PCR (qPCR). Statistical tests and multivariate analysis were performed using RStudio program.Results showed that the proportions of Firmicutes, Akkermansia muciniphila, and Faecalibacterium prausnitzii (P≤0.041), as well as, the ratio Firmicutes/Bacteroidetes decreased in participants with T1DM compared with those without diabetes (p = 0.036). Participants with T2DM presented a reduction in the amounts of A. muciniphila and F. prausnitzii compared with those without diabetes (P≤0.036). Furthermore, A. muciniphila is negatively correlated with glucose level (P=0.022) and glycated hemoglobin (HbA1c) (P=0.035). Multivariate analysis revealed that participants with diabetes formed a cluster apart compared with those without diabetes.In conclusion the gut bacteria of Tunisian participants with diabetes was altered. The gut bacterial profile, especially the distribution of A muciniphila in participants with diabetes was affected by glycemic dysregulation. The investigation of the gut microbiota may help clinicians to improve diagnosis and treatment of diabetes and its complications.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068536 Firmicutes A phylum of predominantly GRAM-POSITIVE BACTERIA that includes the orders Bacillales and Clostridiales. Firmicutes and BACTEROIDETES are the two bacterial phyla that constitute the majority of the human gut MICROBIOTA.

Related Publications

Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
December 2016, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion,
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
June 2016, Frontiers in bioscience (Landmark edition),
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
August 2021, Gut pathogens,
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
November 2023, Cureus,
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
December 2019, Applied microbiology and biotechnology,
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
January 2022, Frontiers in cellular and infection microbiology,
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
May 2020, Gut microbes,
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
April 2015, European journal of endocrinology,
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
August 2021, Nutrients,
Meriem Fassatoui, and Mireia Lopez-Siles, and Diana A Díaz-Rizzolo, and Haifa Jmel, and Chokri Naouali, and Ghaith Abdessalem, and Asma Chikhaoui, and Belén Nadal, and Henda Jamoussi, and Abdelmajid Abid, and Ramon Gomis, and Sonia Abdelhak, and Margarita Martinez-Medina, and Rym Kefi
February 2016, Nature reviews. Endocrinology,
Copied contents to your clipboard!